Cite
HARVARD Citation
Blower, E. et al. (2022). Rivaroxaban targets procoagulant fibroblasts in the tumour microenvironment to reduce breast cancer cell migration and stem cell activity. European journal of surgical oncology. 48 (1), pp. e6-. [Online].